Access1 Access2 Access3 Cancer Medication & Drugs Respiratory July 27, 2022 Tepotinib (Tepmetko) for METex14-altered NSCLC
Access1 Access2 Access3 Cancer Medication & Drugs July 14, 2022 Immune Checkpoint Inhibitors in Oncology: Pembrolizumab (Keytruda)
Access1 Access2 Access3 Cancer Medication & Drugs June 16, 2022 Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo)
Access1 Access2 Cancer Medication & Drugs Women's Health October 3, 2021 Treatment of HER2+ Breast Cancer: Kanjinti, a biosimilar to trastuzumab